ClinicalTrials.gg
CompletedNCT06223087Updated Jun 23, 2026

Effects of Winter Swimming on Blood Indicators and Oxidative Stress in Males

An observational study in Cold Exposure, sponsored by University School of Physical Education, Krakow, Poland. Completed at 1 site in Poland. Open to male participants aged 25 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-23.

Sponsored by University School of Physical Education, Krakow, Poland · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
25 Years to 60 Years
Sex
Male
01

Study summary

Exposure of the human body to cold water triggers numerous beneficial physiological changes. The study aimed to assess the impact of regular winter swimming on blood morphological, rheological, and biochemical indicators and activity of antioxidant enzymes in males. The study includes winter swimmers and a control group. Blood samples were taken twice - before the start (November) of the winter swimming season and after its end (March). The average duration of ice water baths was 3-5 minutes, with a minimum frequency of once a week. The water temperature during the swimming did not exceed 10°C, approaching 0°C during the winter period.

02

Conditions studied

  • Cold Exposure

Keywords

  • blood
  • rheology
  • cold
  • blood morphology
  • biochemistry
  • exercise
03

In context

Common Cold

219 studies on the registry are indexed under Common Cold; 23 are open to participants now.

This study's enrollment of 30 is below the median of 114 across 25 observational studies indexed under Common Cold.

Browse Common Cold studies →

Lead sponsor

University School of Physical Education, Krakow, Poland is the lead sponsor of 21 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Experienced in winter swimming, regularly swimming in cold water (open water) at least once a week in the period November - March

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Good health, practitioners of winter swimming
  • control group: never did winter swimming and had a sedentary lifestyle.

Exclusion criteria

Exclusion Criteria:

  • medical to winter bathing
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No

Groups and cohorts

  • control

    group not practicing winter swimming

  • winter swimmers

    group practicing winter swimming

    Other: winter swimming

Interventions

  • Otherwinter swimming

    Intervention involves bathing/swimming in cold water during the winter months in open waters

06

What researchers measure

Primary outcomes

  1. blood sampling: platelets and leukocytes

    Measurements of: Platelets \[thousands/μl\], Leukocytes \[thousands/μl\], Neutrophils \[thousands/μl\], Eosinophils \[thousands/μl\], Basophils \[thousands/μl\], Lymphocytes \[thousands/μl\], Monocytes \[thousands/μl\].

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  2. blood sampling: erythrocytes

    Measurement of: Erythrocytes \[mln/μl\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  3. blood sampling: haemoglobin

    Determination of: Haemoglobin \[g/dl\], mean corpuscular haemoglobin concentration (MCHC) \[g/dl\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  4. blood sampling: haematocrit

    Determination of: haematocrit \[%\], red blood cell distribution width coefficient of variation (RDW-CV) \[%\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  5. blood sampling: haemoglobin mass

    Determination of: mean corpuscular haemoglobin (MCH) \[pg\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  6. blood sampling: Erythrocytes

    Determination of mean corpuscular volume (MCV) \[fl\], red blood cell distribution width standard deviation (RDW-SD) \[fl\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  7. blood sampling: rheology part 1

    Determination of red cell elongation index (EI) \[arbitrary unit: AU\], erythrocyte aggregation amplitude (AMP) \[AU\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  8. blood sampling: rheology part 2

    Determination of: aggregation index (AI) \[%\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  9. blood sampling:rheology part 3

    Determination of: half-time of total aggregation (t1/2) \[s\].

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  10. blood sampling: oxidative stress

    Measurement of catalase (CAT) \[nmol/min/ml\], and glutathione peroxidase (GPx) \[nmol/min/ml\].

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  11. blood sampling: oxidative stress - superoxide dismutase

    Measurement of superoxide dismutase (SOD) \[U/ml\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  12. blood biochemistry: Urea

    Measurement of: Urea \[mmol/l\].

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  13. blood sampling: Testosterone

    Determination of Testosterone concentration \[ng/dl\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  14. blood sampling: Cortisol

    Determination of Cortisol concentration \[µg/dl\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

  15. blood biochemistry: Creatine

    Determination of Creatinine concentration \[µmol/l\],

    Time frame: twice: before the start of cold swimming in November and 5 months later (March), after the end of winter swimming

07

Study locations

1 site
  • University of Physical Education
    Krakow, 31571, Poland
08

References and documents

Publications

  • Teleglow A, Konieczny K, Dobija I, Kusmierczyk J, Tota L, Rembiasz K, Maciejczyk M. Effect of regular winter swimming on blood morphological, rheological, and biochemical indicators and activity of antioxidant enzymes in males. BMC Sports Sci Med Rehabil. 2024 Jun 21;16(1):138. doi: 10.1186/s13102-024-00932-3. PubMed 38907310 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2021 to primary completion in Dec 2023, 35 months.

Of 12 observational studies under Common Cold, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 35. This study's 35 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 30, 2023
First posted
Jan 25, 2024
StartActual
Jan 1, 2021
Primary completionActual
Dec 31, 2023
CompletionActual
Dec 31, 2024
Last update
Jun 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06223087
Lead sponsor
University School of Physical Education, Krakow, Poland
Responsible party
Aneta Teleglow (Head of Blood Physiology Laboratory, University School of Physical Education, Krakow, Poland) — Principal investigator
First posted
Jan 25, 2024
Start date
Jan 1, 2021
Primary completion
Dec 31, 2023
Completion
Dec 31, 2024
Last update
Jun 23, 2026

Study contacts

Aneta Teleglow
principal investigator · University of Physical Education, Kraków, Poland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion